Caris Life Sciences, Inc. (CAI)
NASDAQ · Healthcare
Caris Life Sciences, Inc. Shareholder Equity 2023–2025
Caris Life Sciences, Inc. annual shareholder equity history from 2024 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Caris Life Sciences, Inc. shareholder equity as of December 31, 2025: 577.3M, a 123.10% decrease year-over-year.
- Caris Life Sciences, Inc. shareholder equity for 2025 were 577.3M, a 123.10% decrease from 2024.
- Caris Life Sciences, Inc. shareholder equity for 2024 were -2.50B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Caris Life Sciences, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $577 |
| 2024 | $-2,499 |
Caris Life Sciences, Inc. Shareholder Equity — FAQ
Caris Life Sciences, Inc. (CAI) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CAI's shareholder equity history?
The chart and table above show Caris Life Sciences, Inc.'s shareholder equity by year and by quarter, including the growth rate.